Law Firm Reminds Investors of Lead-Plaintiff Deadlines in Suits Targeting Gossamer, New Era, Medpace and Stellantis

Overview

• The Law Offices of Frank R. Cruz issued a new reminder inviting shareholders to seek lead-plaintiff roles in securities class actions involving Gossamer Bio, New Era Energy & Digital, Medpace Holdings and Stellantis.
• Filing cutoffs are set for early June 2026, with June 1 for Gossamer and New Era, June 5 for Medpace and June 8 for Stellantis.
• The notices list class periods as follows: Gossamer from June 16, 2025 to February 20, 2026; New Era from November 6, 2024 to December 29, 2025; Medpace from April 22, 2025 to February 9, 2026; Stellantis from February 26, 2025 to February 5, 2026.
• In the Gossamer case, the complaint alleges its Phase 3 PROSERA trial missed its primary goal after Latin American sites enrolled heavily treated, lower-risk patients who performed unusually well on placebo, rendering prior upbeat statements misleading.
• Under the Private Securities Litigation Reform Act, the lead plaintiff helps choose counsel and set the case plan, and the firm’s notice provides contact details with an attorney-advertising disclaimer.